false
0000101538
UNITED STATES ANTIMONY CORP
0000101538
2026-01-05
2026-01-05
0000101538
UAMY:CommonStockOneMember
2026-01-05
2026-01-05
0000101538
UAMY:CommonStockTwoMember
2026-01-05
2026-01-05
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported) January 5, 2026
| UNITED STATES ANTIMONY CORPORATION |
| (Exact name of registrant as specified in its charter) |
| Texas |
|
001-08675 |
|
81-0305822 |
|
(State or other jurisdiction
of incorporation) |
|
(Commission
File No.) |
|
(IRS Employer
Identification Number) |
| 4438
W. Lovers Lane, Unit
100, Dallas,
TX |
|
75209 |
| (Address of principal executive officers) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: (406) 606-4117
Not Applicable
(Former name or former address, if changed since
last report.)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: |
| Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
| Common
Stock, $0.01 par value |
|
UAMY |
|
NYSE
American |
| Common
Stock, $0.01 par value |
|
UAMY |
|
NYSE
Texas |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 7.01 Regulation FD Disclosure
On January 5, 2026, United States Antimony Corporation
issued a letter to its shareholders. A copy of the shareholder letter is attached hereto as Exhibit 99.1 and is incorporated herein by
reference.
In accordance with General Instruction B.2 of Form
8-K, the information contained in Item 7.01 and attached as Exhibit 99.1 is being furnished and shall not be deemed “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject
to the liabilities of that section, nor shall such information and exhibit be incorporated by reference into any filing under the Securities
Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. | |
Description |
| 99.1 | |
Letter to Shareholders, dated January 5, 2026 |
| 104 | |
Cover Page Interactive Data File (embedded with the inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
UNITED STATES ANTIMONY CORPORATION |
| Dated: |
January 5, 2026 |
|
By: |
/s/ Gary C. Evans |
| |
|
|
Gary C. Evans |
| |
|
|
Chief Executive Officer |